Background: The Performance Standards for Antimicrobial Susceptibility Testing, Twelfth Informational Supplement, M100-S12, published by the National Committee for Clinical Laboratory Standards (NCCLS) in January 2002 introduced distinct minimum inhibitory concentration (MIC) interpretative breakpoints for ceftriaxone, cefotaxime, and cefepime for nonmeningeal isolates of Streptococcus pneumoniae. Previously, a single set of interpretative breakpoints was used for both meningeal and nonmeningeal isolates.
Methods: To estimate the rate of adoption of the M100-S12 interpretive breakpoints by clinical laboratories, antimicrobial susceptibility test results for ceftriaxone and cefotaxime from nonmeningeal S. pneumoniae isolates were studied using data collected from January 2002 to June 2003 by The Surveillance Network Database--USA (TSN, an electronic surveillance database.
Results: Of the 262 laboratories that provided data that could be evaluated, 67.6% had adopted the M100-S12 breakpoints one and one-half years after they were published.
Conclusions: The NCCLS M100-S12 recommendation to interpret MICs to expanded-spectrum cephalosporins using two distinct sets of breakpoints for meningeal and nonmeningeal isolates of S. pneumoniae was steadily implemented by clinical microbiology laboratories in the United States following their initial publication in January 2002. The use of these new breakpoints more accurately reflects the clinical activities of expanded-spectrum cephalosporins than did the single set of interpretative breakpoints previously used for both meningeal and nonmeningeal isolates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC324563 | PMC |
| http://dx.doi.org/10.1186/1476-0711-3-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Recent increase in atypical presentations of invasive meningococcal disease in France.
BMC Infect Dis
June 2024
Invasive Bacterial Infections Unit and National Reference Centre for Meningococci and Haemophilus influenzae, Institut Pasteur, Université Paris Cité, 28 rue du Dr Roux, Paris cedex 15, 75724, France.
Article Synopsis
- * A study analyzing IMD cases in France from 2015 to 2022 found an increase in non-meningeal forms, such as pneumonic and abdominal IMD, particularly in older and young adults, respectively.
- * The rise in these atypical forms may result in worse outcomes due to delays in diagnosis, suggesting a need to update vaccination strategies to better respond to these changes in the disease's patterns.
Serotype distribution, clinical characteristics, and antimicrobial resistance of pediatric invasive pneumococcal disease in Colombia during PCV10 mass vaccination (2017-2022).
Front Med (Lausanne)
May 2024
Red Neumocolombia, Bogotá, Colombia.
Article Synopsis
- * A total of 530 patients were reported, with the majority exhibiting pneumonia; the study highlighted high rates of ICU admissions (50.6%) and notable resistance to antibiotics among meningial and non-meningial isolates.
- * The findings indicated a decrease in PCV10 serotypes but an increase in the prevalence of serotypes 19A and 6C, leading to Colombia's decision to switch to the PCV13 vaccine in July 202
Serotype epidemiology and antibiotic resistance of pneumococcal isolates colonizing infants in Botswana (2016-2019).
PLoS One
May 2024
Division of Pediatric Infectious Diseases, Duke School of Medicine, Durham, North Carolina, United States of America.
Background: In 2012, Botswana introduced 13-valent pneumococcal conjugate vaccine (PCV-13) to its childhood immunization program in a 3+0 schedule, achieving coverage rates of above 90% by 2014. In other settings, PCV introduction has been followed by an increase in carriage or disease caused by non-vaccine serotypes, including some serotypes with a high prevalence of antibiotic resistance.
Methods: We characterized the serotype epidemiology and antibiotic resistance of pneumococcal isolates cultured from nasopharyngeal samples collected from infants (≤12 months) in southeastern Botswana between 2016 and 2019.
Increase in Penicillin and multidrug resistance in Streptococcus pneumoniae (1993-2016): Report from a tertiary care hospital laboratory, Pakistan.
J Pak Med Assoc
December 2021
Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.
Objective: To determine the trend of resistance to antimicrobials in Streptococcus pneumoniae infections, and the impact of new Clinical and Laboratory Standards Institute guidelines on 1211 among meningeal isolates.
Methods: The descriptive observational retrospective study was conducted at the Aga Khan University Hospital laboratory in Karachi, and comprised Streptococcus pneumoniae isolation and antimicrobial susceptibility data over a period of 24 years, from 1993 to 2016, which was compared in terms of pre-2008 and post-2008 data, which was analysed using SPSS 19.
Results: Of the 7415 non-duplicate isolates identified, 4700(63.
Emergence of serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10.
Hum Vaccin Immunother
September 2020
Universidad Nacional de Colombia , Bogotá, Colombia.
Article Synopsis
- The introduction of pneumococcal conjugate vaccines (PCV) has significantly reduced the incidence of invasive pneumococcal disease (IPD), leading to a decrease in vaccine-associated serotypes, but has resulted in the emergence of non-vaccine serotypes like 19A.
- A study conducted on pediatric patients with IPD from 2008 to 2017 in Bogota examined cases related to the implementation of the PCV10 vaccine, focusing on various infections and analyzing demographic and clinical data.
- The prevalence of IPD caused by serotype 19A increased from 4.4% (2008-2011) to 32.4% (2014-2017), with pneumonia being the
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!